These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15806473)

  • 1. Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients.
    Mallamaci F; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Candela V; Scudo P; Spoto B; Testa A; Tripepi G; Tech S; Zoccali C
    Am J Kidney Dis; 2005 Apr; 45(4):702-7. PubMed ID: 15806473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency?
    Tai HC; Yang WC; Chen TW; Lin CC
    Am J Kidney Dis; 2005 Nov; 46(5):993-4; author reply 994. PubMed ID: 16253747
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
    Fukasawa M; Matsushita K; Kamiyama M; Mikami Y; Araki I; Yamagata Z; Takeda M
    Am J Kidney Dis; 2003 Mar; 41(3):637-42. PubMed ID: 12612987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
    Hagen W; Födinger M; Heinz G; Buchmayer H; Hörl WH; Sunder-Plassmann G
    Kidney Int Suppl; 2001 Feb; 78():S253-7. PubMed ID: 11169021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis.
    Tamura T; Bergman SM; Morgan SL
    Am J Kidney Dis; 1998 Sep; 32(3):475-81. PubMed ID: 9740165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.
    Marcucci R; Giusti B; Betti I; Evangelisti L; Fedi S; Sodi A; Cappelli S; Menchini U; Abbate R; Prisco D
    Thromb Res; 2003 Apr; 110(1):7-12. PubMed ID: 12877902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.
    Kimura H; Gejyo F; Suzuki S; Miyazaki R
    J Am Soc Nephrol; 2000 May; 11(5):885-893. PubMed ID: 10770966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and polymorphisms of the methylenetetrahydrofolate gene in hemodialysis and peritoneal dialysis patients.
    Domenici FA; Vannucchi MT; Simões-Ambrósio LM; Vannucchi H
    Mol Nutr Food Res; 2007 Nov; 51(11):1430-6. PubMed ID: 17966140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
    Morimoto K; Haneda T; Okamoto K; Ishida H; Kikuchi K
    Nephron; 2002 Jan; 90(1):43-50. PubMed ID: 11744804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of thrombotic risk factors in end-stage renal disease.
    Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
    Saifan C; El-Charabaty E; El-Sayegh S
    Vasc Health Risk Manag; 2013; 9():361-4. PubMed ID: 23898227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.